As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
glioblastoma
Biotech company acquires OMRF brain cancer drug
Agreement will expand clinical trials of glioblastoma drug
New OMRF vice president focuses on bringing discoveries to the world
Technology Ventures works to pair scientists with industry partners.
Biomarkers help doctors decide how to treat brain cancers
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.
OMRF brain cancer drug enters clinical trials at OU cancer center
OMRF, Stephenson Cancer Center begin tests of experimental compound
Attacking cancer on multiple fronts
Cutting off avenues for growth is key to killing tumors.
